Driving the need to feed: Insight into the collaborative interaction between ghrelin and endocannabinoid systems in modulating brain reward systems

Neuroscience and Biobehavioral Reviews

Volumn 66, Issue , 2016, Pages 33-53

  Edwards, Alexander ^a   Abizaid, Alfonso ^a  

^a CARLETON UNIVERSITY   (Canada)

Author keywords

Adiposity; CB 1Rs; Endocannabinoids; Food intake; Ghrelin; GHSRs; Interaction; VTA

Indexed keywords

ADENOSINE MONOPHOSPHATE ACTIVATED PROTEIN KINASE; ENDOCANNABINOID; GHRELIN; PROTEIN KINASE; UNCLASSIFIED DRUG;

DOPAMINERGIC SYSTEM; ENZYME ACTIVITY; ENZYME REGULATION; FEEDING BEHAVIOR; HORMONE ACTION; HORMONE RELEASE; HUMAN; HYPOTHALAMUS; INTRACELLULAR SIGNALING; NONHUMAN; PRIORITY JOURNAL; REVIEW; REWARD; VENTRAL TEGMENTUM; BRAIN;

BRAIN; ENDOCANNABINOIDS; GHRELIN; REWARD; VENTRAL TEGMENTAL AREA;

EID: 84964558182     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2016.03.032     Document Type: Review

References (344)

1. s. J. Neurochem. 1999, 72:2032-2038.
2. Abizaid A., Horvath T.L. Brain circuits regulating energy homeostasis. Regul. Pept. 2008, 149:1-16.
3. Abizaid A., Horvath T.L. Ghrelin and the central regulation of feeding and energy balance. Indian J. Endocrinol. Metab. 2012, S3:617-626.
4. Abizaid A., Liu Z.W., Andrews Z.B., Shanabrough M., Borok E., Elsworth J.D., Roth R.H., Sleeman M.W., Picciotto M.R., Tschop M.H., Gao X.B., Horvath T.L. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J. Clin. Invest. 2006, 116(12):3229-3239.
5. Abizaid A. Ghrelin and dopamine: new insights on the peripheral regulation of appetite. J. Neuroendocrinol. 2009, 21(9):787-793.
6. Alcaro A., Huber R., Panksepp J. Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective. Brain Res. Rev. 2007, 56(2):283-321.
7. Alen F., Crespo I., Ramirez-Lopez M.T., Jagerovic N., Goya P., Rodriguez de Fonseca F., Gomez de Heras R., Orio L. Ghrelin-induced orexigenic effect in rats depends on the metabolic status and is counteracted by peripheral CB1 receptor antagonism. PLoS One 2013, 8(4):60918-60924.
8. Alger B.E., Kim J. Supply and demand for endocannabinoids. Trends Neurosci. 2011, 34(6):304-315.
9. Alger B.E. Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. Prog. Neurobiol. 2002, 68:247-286.
10. Anderson K.A., Ribar T.J., Lin F., Noeldner P.K., Green M.F., Muehilbauer M.J., Witters L.A., Kemp B.E., Means A.R. Hypothalamic CaMKK2 contributes to the regulation of energy balance. Cell Metab. 2008, 7:377-388.
11. Andersson U., Filipsson K., Abbott C.R., Woods A., Smith K., Bloom S.R., Carling D., Small C.J. AMP-activated protein kinase plays a role in the control of food intake. J. Biol. Chem. 2004, 279(13):12005-12008.
12. Andrews Z.B., Liu Z.W., Wallingford N., Erion D.M., Borok E., Friedman J.M., Tschop M.H., Shanabrough M., Cline G., Shulman G.I., Coppola A., Gao X.B., Horvath T.H., Diano S. UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals. Nature 2008, 454:846-851.
13. Andrews Z.B. Central mechanisms involved in the orexigenic actions of ghrelin. Peptides 2011, 32:2248-2255.
14. Ariyasu H., Takaya K., Tagami T., Ogawa Y., Hosoda K., Akamizu T., Suda M., Koh T., Natsui K., Toyooka S., Shirakami G., Usui T., Shimatsu A., Doi K., Hosoda H., Kojima M., Kangawa K., Nakao K. Stomach is a major source of circulating ghrelin: and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J. Clin. Endocrinol. Metab. 2001, 86:4753-4758.
15. Arnone M., Maruani J., Chaperon F., Thiebot M., Poncelet M., Soubrie P., Le Fur G. Selective inhibition of sucrose and ethanol intake by SR. 141716: an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology (Berl.) 1997, 132:104-106.
16. Asakawa A., Inui A., Kaga T., Yuzuriha H., Nagata T., Fujimiya M., Katsuura G., Makino S., Fujino M.A., Kasuga M. A role of ghrelin in neuroendocrine and behavioral responses to stress in mice. Neuroendocrinology 2001, 74(3):143-147.
17. Asakawa A., Inui A., Kaga T., Katsuura G., Fujimiya M., Fujino M.A., Kasuga M. Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut 2003, 52(7):947-952.
18. Asakawa A., Inui A., Fujimiya M., Sakamaki R., Shinfuku N., Ueta Y., Meguid M.M., Kasuga M. Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut 2005, 54:18-24.
19. Badiani A., Leone P., Noel M.B., Stewart J. Ventral tegmental area opioid mechanisms and modulation of ingestive behaviour. Brain Res. 1995, 670:264-276.
20. Baker D., Pryce G., Davies W.L., Hiley C.R. In silico patent searching reveals a new cannabinoid receptor. Trends Pharmacol. Sci. 2006, 27(1):1-4.
21. Balcita-pedicino J.J., Omelchenko N., Bell R., Sesack S.R. The inhibitory influence of the lateral habenula on midbrain dopamine cells: ultrastructural evidence for indirect mediation via the rostromedial mesopontine tegmental nucleus. J. Comp. Neurol. 2011, 519(6):1143-1164.
22. s GTP-binding proteins and cAMP formation. Neurosignals 2003, 12:39-44.
23. Bayer V.E., Pickel V.M. GABA-labeled terminals form proportionally more synapses with dopaminergic neurons containing low densities of tyrosine hydroxylase immunoreactivity in rat ventral tegmental area. Brain Res. 1991, 559:44-55.
24. Bednarek M.A., Feighner S.D., Pong S.S., McKee K.K., Hreniuk D.L., Silva M.V., Warren V.A., Howard A.D., Van Der Ploeq L.H., Heck J.V. Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J. Med. Chem. 2000, 43(23):4370-4376.
25. Befort K. Interactions of the opioid and cannabinoid systems in reward: insights from knockout studies. Frontiers in Pharamacology 2015, 6(6). 115.
26. Bellocchio L., Lafenetre P., Cannich A., Cota D., Puente N., Grandes P., Chaouloff F., Piazza P.V., Marsicano G. Bimodal control of stimulated food intake by the endocannabinoid system. Nat. Neurosci. 2010, 13(3):281-283.
27. Bennett P.A., Thomas G.B., Howard A.D., Feighner S.D., Van Der Ploeg L.H., Smith R.G., Robinson I.C. Hypothalamic growth hormone secretagogue-receptor (GHS-R) expression is regulated by growth hormone in the rat. Endocrinology 1997, 138(11):4552-4557.
28. Bermudez-Silva F.J., Cardinal P., Cota D. The role of the endocannabinoid system in the neuroendocrine regulation of energy balance. J. Psychopharmacol. (Oxf.) 2012, 26(1):114-124.
29. Berridge K.C., Robinson T.E. Parsing reward. Trends Neurosci. 2003, 26(9):507-513.
30. Berridge K.C. Food reward: brain substrates of wanting and liking. Neurosci. Biobehav. Rev. 1996, 20(1):1-25.
31. Berridge K.C. Motivation concepts in behavioral neuroscience. Physiol. Behav. 2004, 81:179-209.
32. Berridge K.C. Liking and wanting food rewards: brain substrates and roles in eating disorders. Physiol. Behav. 2009, 97:537-550.
33. Berthoud H.R. Homeostatic and non-homeostatic pathways involved in the control of food intake and energy balance. Obesity 2006, 14:197-200.
34. Biazquez C., Sanchez C., Daza A., Galve-Roperh I., Guzman M. The stimulation of ketogenesis by cannabinoids in cultured astrocytes defines carnitine palmitoyltransferase I as a new ceramide-activated enzyme. J. Neurochem. 1999, 72(4):1759-1768.
35. Bisogno T., Berrendero F., Ambrosino G., Cebeira M., Ramos J.A., Fernandez-Ruiz J.J., Di Marzo V. Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function. Biochem. Biophys. Res. Commun. 1999, 256:377-380.
36. Bjorklund A., Dunnett S.B. Dopamine neuron systems in the brain: an update. Trends Neurosci. 2007, 30(5):194-202.
37. Black S.C. Cannabinoid receptor antagonists and obesity. Curr. Opin. Investig. Drugs 2004, 5:389-394.
38. Bosier B., Muccioli G.G., Hermans E., Lambert D.M. Functionally selective cannabinoid receptor signalling: therapeutic implications and opportunities. Biochem. Pharmacol. 2010, 80:1-12.
39. Bouaboula M., Poinot-Chazel C., Bourrie B., Canat X., Calandra B., Rinaldi-Carmona M., Le Fur G., Casellas P. Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem. J 1995, 312:637-641.
40. Bourdy R., Barrot M. A new control center for dopaminergic systems: pulling the VTA by the tail. Trends Neurosci. 2012, 35(11):681-690.
41. Broglio F., Benso A., Gottero C., Prodam F., Gauna C., Filtri L., Arvat E., Van Der Lely A.J., Deghenghi R., Ghigo E. Non-acylated ghrelin does not possess the pituitaric and pancreatic endocrine activity of acylated ghrelin in humans. J. Endocrinol. Invest. 2003, 26(3):192-196.
42. Broglio F., Gottero C., Benso A., Prodam F., Destefanis S., Gauna C., Maccario M., Deghenghi R., Van Der Lely A.J., Ghigo E. Effects of ghrelin on the insulin and glycemic responses to glucose, arginine, or free fatty acids load in humans. J. Clin. Endocrinol. Metab. 2003, 88(9):4268-4272.
43. Broglio F., Gottero C., Prodam F., Gauna C., Muccioli G., Papotti M., Abribat T., Van Der Lely A.J., Ghigo E. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. J. Clin. Endocrinol. Metab. 2004, 89(6):3062-3065.
44. Bruijnzeel A.W., Corrie L.W., Rogers J.A., Yamada H. Effects of insulin and leptin in the ventral tegmental area and arcuate hypothalamic nucleus on food intake and brain reward function in female rats. Behav. Brain Res. 2011, 219(2):254-264.
45. Burdyga G., Varro A., Dimaline R., Thompson D.G., Dockray G.J. Ghrelin receptors in rat and human nodose ganglia: putative role in regulating CB-1and MCH receptor abundance. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290:1289-1297.
46. Cahill S.P., Hatchard T., Abizaid A., Holahan M.R. An examination of early and cognitive alterations in hippocampal-spatial function of ghrelin receptor-deficient rats. Behav. Brain Res. 2014, 264:105-115.
47. Calendra B., Portier M., Kerneis A., Delpech M., Carillon C., Le Fur G., Ferrara P., Shire D. Dual intracellular signalling pathways mediated by human cannabinoid CB1 receptor. Eur. J. Pharmacol. 1999, 374:445-455.
48. Cani P.D., Montoya M.L., Neyrinck A.M., Delzenne N.M., Lambert D.M. Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR 141716A (rimonabant) and oleoylethanolamide. Br. J. Nutr. 2004, 92:757-761.
49. Carriba P., Navarro G., Ciruela F., Ferre S., Casado V., Agnati L., Cortes A., Mallol J., Canela E., Fuxe K., Lluis C., Franco R. Detection of heteromerization of more than two proteins by sequential BRET-FRET. Nat. Methods 2008, 5:727-733.
50. Castillo P.E., Younts T.J., Chavez A.E., Hashimotodani Y. Endocannabinoid signaling and synaptic function. Neuron 2012, 76(1):70-81.
51. Chaperon F., Soubrie P., Puech A.J., Thiebot M.H. Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats. Psychopharmacology (Berl.) 1998, 135:324-332.
52. Cheer J.F., Marsden C.A., Kendall D.A., Mason R. Lack of response supression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiology study. Neuroscience 2000, 99:661-667.
53. Chen J.P., Paredes W., Li J., Smith D., Lowinson J., Gardner E.L. Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology 1990, 102:156-162.
54. Chen C., Inui A., Asakawa A., Fujino K., Kato I., Chen C., Ueno N., Fujimiya M. Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats. Gasteroenterology 2005, 129:8-25.
55. Chuang J.C., Perello M., Sakata I., Osborne-Lawrence S., Savitt J.M., Lutter M., Zigman J.M. Ghrelin mediates stress-induced food-reward behavior in mice. J. Clin. Invest. 2011, 121:2684-2692.
56. Collins S.P., Reoma J.L., Gamm D.M., Uhler M.D. LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by cAMP-dependent protein (PKA) and prenylated in vivo. Biochem. J 2000, 345(Pt 3):673-680.
57. Colombo G., Agabio R., Diaz G., Lobina C., Reali R., Gessa G.L. Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sci. 1998, 63:113-117.
58. Cone J.J., Roitman J.D., Roitman M.F. Ghrelin regulates phasic dopamine and nucleus accumbens signaling evoked by food-predictive stimuli. J. Neurochem. 2015, 133:844-856.
59. Cota D., Marsicano G., Tschop M., Gruebler Y., Flachskamm C., Schubert M., Auer D., Yassouridis A., Thone-Reineke C., Ortmann S., Tomassoni F., Cervino C., Nisoli E., Linthorst A.C., Pasquali R., Lutz B., Stalla G.K., Pagotto U. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J. Clin. Invest. 2003, 112:423-431.
60. Cowley M.A., Smith R.G., Diano S., Tshop M., Pronchuk N., Grove K.L., Strasburger C.J., Bidlingmaier M., Esterman M., Heiman M.L., Garcia-Segura L.M., Nillni E.A., Mendez P., Low M.J., Sotonyi P., Friedman J.M., Liu H., Pinto S., Colmer W.F., Cone R.D., Horvath T.L. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 2003, 37:649-661.
61. Cummings D.E., Foster K.E. Ghrelin-leptin tango in bodyweight regulation. Gastroenterology 2003, 124:1532-1535.
62. D'Addario C., Micioni Bonaventura M.V., Pucci M., Romano A., Gaetani S., Ciccocioppo R., Cifani C., Maccarrone M. Endocannabinoid signaling and food addiction. Neurosci. Biobehav. Rev. 2014, 47:203-224.
63. Date Y., Kojima M., Hosoda H., Sawaguchi A., Mondal M.S., Suganuma T., Matsukura S., Kangawa K., Nakazato M. Ghrelin, a novel growth hormone-releasing acylated peptide: is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000, 141:4255-4261.
64. Date Y., Murakami N., Toshinai K., Matsukura S., Niijima A., Matsuo H., Kangawa K., Nakazato M. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 2002, 123:1120-1128.
65. Daval M., Foufelle F., Ferre P. Functions of AMP-activated protein kinase in adipose tissue. J. Physiol. (Lond.) 2006, 574:55-62.
66. Davis K.W., Wellman P.J., Clifford P.S. Augmented cocaine conditioned place preference in rats pretreated with systemic ghrelin. Regul. Pept. 2007, 140:148-152.
67. De Petrocellis L., Marini P., Matias I., Moriello A.S., Starowicz K., Cristino L., Nigam S., Di Marzo V. Mechanisms for the coupling of cannabinoid receptors to intracellular calcium mobilization in rat insulinoma β-cells. Exp. Cell Res. 2007, 313(14):2993-3004.
68. Delhanty P.J.D., Neggers S.J., Van Der Lely A.J. Ghrelin: the differences between acyl- and des-acyl ghrelin. Eur. J. Endocrinol. 2012, 167:601-608.
69. Devane W.A., Dysarz F.A., Johnson M.R., Melvin L.S., Howlett A.C. Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 1988, 34:605-613.
70. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258:1946-1949.
71. Di Marzo V., Cristino L. Why endocannabinoids are not all alike. Nat. Neurosci. 2008, 11(2):124-126.
72. Di Marzo V., Fontana A. Anandamide, an endogenous cannabinomimetic eicosanoid: 'killing two birds with one stone'. Prostaglandins Leukot. Essent. Fatty Acids 1995, 53:1-11.
73. Di Marzo V., Goparaju S.K., Wang L., Liu J., Batkai S., Jarai Z., Fezza F., Minura G.L., Palmiter R.D., Sungiura T., Kunos G. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001, 410:822-825.
74. Di Marzo V.D., Ligresti A., Cristino L. The endocannabinoid system as a link between homeostatic and hedonic pathways involved in energy balance regulation. Int. J. Obes. 2009, 33:518-524.
75. Di S., Malcher-Lopes R., Halmos K.C., Tasker J.G. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J. Neurosci. 2003, 23(12):4850-4857.
76. Di S., Malcher-Lopes Marcheselli V.L., Bazan N.G., Tasker J.G. Rapid glucocorticoid-mediated endocannabinoid release and opposing regulation of glutamate and γ-Aminobutyric acid inputs to hypothalamic magnocellular neurons. Endocrinology 2005, 145(10):4292-4301.
77. Diano S., Farr S.A., Benoit S.C., McNay E.C., da Silva I., Horvath B., Gaskin S.F., Nonaka N., Jaeger L.B., Banks W.A., Morley J.E., Pinto S., Sherwin R.S., Xu L., Yamada K.A., Sleeman M.W., Tschop M.H., Horvath T.L. Ghrelin controls hippocampal spine synapse density and memory performance. Nat. Neurosci. 2006, 9(3):381-388.
78. Dickson S.L., Hrabovszky E., Hansson C., Jerlhag E., Alvarez-Crespo M., Skibicka K.P., Molnar C.S., Liposits Z., Engel J.A., Egecioglu E. Blockage of central nicotine acetylcholine receptor signaling attenuate ghrelin-induced food intake in rodents. Neuroscience 2010, 171:1180-1186.
79. Dickson S.L., Egecioglu E., Landgren S., Skibicka K.P., Engel J.A., Jerlhag E. The role of the central ghrelin system in reward from food and chemical drugs. Mol. Cell. Endocrinol. 2011, 340(1):80-87.
80. Dietrich M., Horvath T.L. Hypothalamic control of energy balance: insights into the role of synaptic plasticity. Trends Neurosci. 2013, 36(2):65-73.
81. Disse E., Bussier A.L., Veyrat-Durebex C., Deblon N., Pfluger P.T., Tschop M.H., Laville M., Rohner-Jeanrenaud F. Peripheral ghrelin enhances sweet taste food consumption and preference: regardless of its caloric content. Physiol. Behav. 2010, 101:277-281.
82. Dobi A., Margolis E.B., Wang H.L., Harvey B.K., Morales M. Glutamatergic and non-glutamatergic neurons of the ventral tegmental area establish local synaptic contacts with dopaminergic and non-dopaminergic neurons. J. Neurosci. 2010, 30(1):218-219.
83. Dornonville de la Cour C., Bjorkqvist M., Sandvik A.K., Bakke I., Zhao C.M., Chen D., Hakanson R. A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control. Regul. Pept. 2001, 99(2-3):141-150.
84. Drazen D.L., Vahl T.P., D'Alessio D.A., Seeley R.J., Woods S.C. Effect of a fixed meal pattern on ghrelin secretion: evidence for a learned response independent of nutrient status. Endocrinology 2006, 147(1):23-30.
85. Egecioglu E., Jerlhag E., Salome N., Skibicka K.P., Haage D., Bohlooly Y.M., Andersson D., Bjursell M., Perrissoud D., Engel J.A., Dickson S.L. Ghrelin increases intake of rewarding food in rodents. Addict. Biol. 2010, 15:304-311.
86. Egertova M., Simon G.M., Cravatt B.F., Elphick M.R. Localization of N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) expression in mouse brain: a new perspective on N-acylethanolamines as neural signaling molecules. J. Comp. Neurol. 2008, 506:604-615.
87. Ellis J., Pediani J.D., Canals M., Milasta S., Mulligan G. Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function. J. Biol. Chem. 2006, 281:38812-38824.
88. Farkas I., Vastagh C., Sarvari M., Liposits Z. Ghrelin decreases firing activity of gonadotropin-releasing hormone (GnRH) neurons in an estrous cycle and endocannabinoid signaling dependent manner. PLoS One 2013, 8(10):e78178.
89. Ferrini F., Salio C., Lossi L., Merighi A. Ghrelin in central neurons. Current Neuropharmacol. 2009, 7:37-49.
90. Filipeanu C.M., deZeeuw D., Nelemans S.A. Delta(9)-tetrahydrocannabinol activates [Ca2+], increases partly sensitive to capacitative store refilling. Eur. J. Pharmacol. 1997, 336(1):1-3.
91. Fine P., Rosenfeld M.J. The endocannabinoid system, cannabinoids, and pain. Rambam Maimonides Med. J. 2013, 4(4):1-15.
92. French E.D., Dillon K., Wu X.F. Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra. Neuroreport 1997, 8:649-652.
93. French E.D. Delta 9-tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors. Neurosci. Lett. 1997, 226:159-162.
94. Gao Q., Horvath T.L. Neurobiology of feeding and energy expenditure. Annu. Rev. Neurosci. 2007, 30:367-398.
95. Gaoni Y., Mechoulam R. Isolation, structure: and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc. 1964, 86:1646-1647.
96. Garcia M.C., Lopez M., Alvarez C.V., Casanueva F., Tena-Sempere M., Dieguez C. Role of ghrelin in reproduction. J. Soc. Reprod. 2007, 133:531-540.
97. Garzon M., Pickel V.M. Plasmalemmal μ-opioid receptor distribution mainly in nondopaminergic neurons in the rat ventral tegmental area. Synapse 2001, 41:311-328.
98. Gauna C., Van de Zande B., Van Kerkwijk A., Themmen A.P., Van Der Lely A.J., Delhanty P.J. Unacylated ghrelin is not a functional antagonist but a full agonist of the type 1a growth hormone secretagogue receptor (GHS-R). Mol. Cell. Endocrinol. 2007, 274:30-34.
99. Gessa G.L., Melis M., Muntoni A.L., Diana M. Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors. Eur. J. Pharmacol. 1998, 341:39-44.
100. Ghozland S., Matthes H.W.D., Simonin F., Filliol D., Kieffer B.L., Maldonado R. Motivational effects of cannabinoids are mediated by μ-opioid and Κ-opioid receptors. J. Neurosci. 2002, 22:1146-1154.
101. Gifford A.L., Gardner E.I., Ashby C.R. The effect of intravenous tetrahydrocannabinol on the activity of A10 dopamine neurons recorded in vivo on anesthetized rats. Neuropsychobiology 1997, 36:96-99.
102. s linkage to the CB1 receptor. J. Neurosci. 1997, 17(14):5327-5333.
103. Gnanapavan S., Kola B., Bustin S.A., Morris D.G., McGee P., Fairclough P., Bhattacharya S., Carpenter R., Grossman A.B., Korbonits M. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R: in humans. J. Clin. Endocrinol. Metab. 2002, 87:2988-2991.
104. Goldstone A., Prechtl C.G., Scholtz S., Miras A.D., Chhina N., Durighel G., Deliran S.S., Beckmann C., Ghatei M.A., Ashby D.R., Waldman A.D., Gaylinn B.D., Thorner M.O., Frost G.S., Bloom S.R., Bell J.D. Ghrelin mimics fasting to enhance human hedonic, orbitofrontal cortex, and hippocampal responses to food. Am. J. Clin. Nutr. 2014, 99(6):1319-1330.
105. Gomez R., Navarro M., Ferrer B., Trigo J.M., Bilbao A., Del Acro I., Cippitelli A., Nava F., Piomelli D., Rodriguez de Fonesca F. A peripheral mechanism for CB1 cannabinoid receptor dependent modulation of feeding. J. Neurosci. 2002, 22(21):9612-9617.
106. Grace A.A., Floresco S.B., Goto Y., Lodge D.J. Regulation of firing of dopaminergic neurons and control of goal-directed behaviours. Trends Neurosci. 2007, 30(5):220-227.
107. Granata R., Settanni F., Biancone L., Trovato L., Nano R., Bertuzzi F., Destefanis S., Annunziata M., Martinetti M., Catapano F., Ghe C., Isqaard J., Papotti M., Ghigo E., Muccioli G. Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic β-cells and human islets: involvement of 3',5'-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-kinase/Akt signaling. Endocrinology 2007, 148:512-529.
108. Gualillo O., Caminos J.E., Kojima M., Kangawa K., Arvat E., Ghigo E., Casanueva F.F., Diéguez C. Gender and gonadal influences on ghrelin mRNA levels in rat stomach. Eur. J. Endocrinol. 2001, 144:687-690.
109. Guan X.M., Yu H., Palyha O.C., McKee K.K., Feighner S.D., Sirinathsinghji D.J., Smith R.G., Van Der Ploeg L.H., Howard A.D. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Mol. Brain. Res. 1997, 48:23-29.
110. Gutierrez J.A., Solenberg P.J., Perkins D.R., Willency J.A., Knierman M.D., Jin Z., Witcher D.R., Luo S., Onyia J.E., Hale J.E. Ghrelin octanoylation mediated by an orphan lipid transferase. Proc. Natl. Acad. Sci. U.S.A. 2008, 105(17):6320-6325.
111. Ha J., Daniel S., Broyles S.S., Kim K.H. Critical phosphorylation sites for acetyl-CoA carboxylase activity. J. Biol. Chem. 1994, 269(35):22162-22168.
112. Hao S., Avraham Y., Mechoulam R., Berry E.M. Low dose anandamide affects food intake, cognitive function: neurotransmitter and corticosterone levels in diet-restricted mice. Eur. J. Pharmacol. 2000, 392:147-156.
113. Hardie D.G., Carling D. The AMP-activated protein kinase-fuel gauge of the mammalian cell?. Eur. J. Biochem. 1997, 246(2):259-273.
114. Hardie D.G., Carling D., Carlson M. The AMP-activated/SFN1 protein kinase subfamily: metabolic sensors of the eukaryotic cell?. Annu. Rev. Biochem. 1998, 67:821-855.
115. Hardie D.G., Hawley S.A., Scott J.W. AMP-activated protein kinase- development of the energy sensor concept. J. Physiol. 2006, 571(1):7-15.
116. Hardie G.D. AMPK: a target for drugs and natural products with effects on both diabetes and cancer. Diabetes 2013, 63:2164-2172.
117. Hariri A.R., Gorka A., Hyde L.W., Kimak M., Halder I., Ducci F., Ferrell R.E., Goldman D., Manuck S.B. Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function. Biol. Psychiatry 2009, 66(1):9-16.
118. Hawley S.A., Boudeau J., Reid J.L., Mustard K.J., Udd L., Makela T.P., Alessi D.R., Hardie D.G. Complexes between the LKB1 tumor suppressor STRADα/β and MO25α/β are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2003, 2(4). 28, 1-28, 16.
119. Hawley S.A., Pan D.A., Mustard K.J., Ross L., Bain J., Edelman A.M., Frenguelli B.G., Hardie D.G. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2005, 2:9-19.
120. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 1991, 11(2):563-583.
121. Hernandez M., Berrendero F., Suarez I., Garcia-Gil L., Cebeira M., Mackie K., Ramos J.A., Fernandez-Ruiz J. Cannabinoid CB1 receptors colocalize with tyrosine hydroxylase in cultured fetal mesencephalic neurons and their activation increases the levels of this enzyme. Brain Res. 2000, 857:57-65.
122. Hommel J.D., Trinko R., Sears R.M., Georgescu D., Liu Z.W., Gao X.B., Thurmon J.J., Marinelli M., DiLeone R.J. Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron 2006, 51(6):801-810.
123. Hong S., Jhou T.C., Smith M., Saleem K.S., Hikosaka O. Negative reward signals from the lateral habenula to dopamine neurons are mediated by rostromedial tegmental nucleus in primates. J. Neurosci. 2011, 31:11457-11471.
124. Horvath T.L., Abizaid A., Dietrich M.O., Li Y., Takahashi J.S., Bass J. Ghrelin-immunopositive hypothalamic neurons tie the circadian clock and visual system to the lateral hypothalamic arousal center. Mol. Metab. 2012, 1:79-85.
125. Horvath T.L. Synaptic plasticity in energy balance regulation. Obesity 2006, 8:228-233.
126. Hosoda H., Kojima M., Matsuo H., Kangawa K. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem. Biophysical Res. Commun. 2000, 279(3):909-913.
127. Houston D.B., Howlett A.C. Differential receptor-G-protein coupling evoked by dissimilar cannabinoid receptor agonists. Cell. Signal. 1998, 10:667-674.
128. Howard A.D., Feighner S.D., Cully D.F., Arena J.P., Liberator P.A., Rosenblum C.I., Hamelin M., Hreniuk D.L., Palyha O.C., Anderson J., Paress P.S., Diaz C., Chou M., Liu K.K., McKee K.K., Pong S.S., Chaung L.Y., Elbrecht A., Dashkevicz M., Heavens R., Rigby M., Sirinathsinghji D.J., Dean D.C., Melillo D.G., Patchett A.A., Nargund R., Griffin P.R., DeMartino J.A., Gupta S.K., Schaeffer J.M., Smith R.G., Van Der Ploeg L.H. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996, 273:974-977.
129. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., Felder C.C., Herkenham M., Mackie K., Martin B.R., Mechoulam R., Pertwee R.G. International union of pharmacology: XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 2002, 54:161-202.
130. 1 cannabinoid receptors and their associated proteins. Cur. Med. Chem. 2010, 17(14):1382-1393.
131. Howlett A.C. Cannabinoid inhibition of adenylate cyclase: biochemistry of the response in neuroblastoma cell membranes. Mol. Pharmacol. 1985, 27:429-436.
132. Howlett A.C. The cannabinoid receptors. Prostaglandins Other Lipid Mediat. 2002, 6869:619-631.
133. Hutchinson D.S., Summers R.J., Bengtsson T. Regulation of AMP-activated protein kinase activity by G-protein coupled receptors: potential utility in treatment of diabetes and heart disease. Pharmacol. Ther. 2008, 119:291-310.
134. Inhoff T., Monnikes H., Noetzel S., Stengel A., Goebel M., Dinh Q.T., Riedl A., Bannert N., Wisser A.S., Wiedenmann B., Klapp B.F., Tache Y., Kobelt P. Desacyl ghrelin inhibits the orexigenic effect of peripherally injected ghrelin in rats. Peptides 2008, 29:2159-2168.
135. Iremonger K.J., Bains J.S. Retrograde opioid signaling regulates glutamatergic transmission in the hypothalamus. J. Neurosci. 2009, 29(22):7349-7358.
136. Jamshidi N., Taylor D.A. Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br. J. Pharmacol. 2001, 134:1151-1154.
137. a-subunit coupling of the CB1 cannabinoid receptor. J. Pharmacol. Exp. Ther. 2004, 308:880-886.
138. Jarrett M.M., Limebeer C.L., Parker L.A. Effect of delta9-tetrahydrocannabinol on sucrose palatability as measured by the taste reactivity test. Physiol. Behav. 2005, 86:475-479.
139. Jarrett M.M., Scantlebury J., Parker L.A. Effect of delta(9)-tetrahydrocannabinol on quinine palatability and AM251 on sucrose and quinine palatability using the taste reactivity test. Physiol. Behav. 2007, 90:425-430.
140. Jbilo O., Ravinet-Trillou C., Arnone M., Buisson I., Bribes E., Peleraux A., Penarier G., Soubrie P., Le Fur G., Galiegue S., Casellas P. The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance. J. Fed. Am. Soc. Exp. Biol. 2005, 19:1567-1569.
141. Jerlhag E., Engel J.A. Ghrelin receptor antagonism attenuates nicotine-induced locomotor stimulation: accumbal dopamine release and conditioned place preference in mice. Drug Alcohol Depend. 2011, 117(2-3):126-131.
142. Jerlhag E., Egecioglu E., Dickson S.L., Douhan A., Svensson L., Engel J.A. Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens. Addict. Biol. 2007, 12(1):6-16.
143. Jerlhag E., Egecioglu E., Landgren S., Salome N., Heilig M., Moechars D., Datta R., Perrissoud D., Dickson S.L., Engel J.A. Requirement of central ghrelin signaling for alcohol reward. Proc. Natl. Acad. Sci. U.S.A. 2009, 106(27):11318-11323.
144. Jerlhag E., Egecioglu E., Dickson S.L., Engel J.A. Ghrelin receptor antagonism attenuates cocaine- and amphetamine- induced locomotor stimulation, accumbal dopamine release, and conditioned place preference. Psychopharmacology (Berl.) 2010, 211(4):415-422.
145. Jerlhag E., Egecioglu E., Dickson S.L., Engel J.A. Glutamatergic regulation of ghrelin-induced activation of the mesolimbic dopamine system. Addict. Biol. 2011, 16(1):82-91.
146. Jerlhag E., Landgren S., Egecioglu E., Dickson S.L., Engel J.A. The alcohol-induced locomotor stimulation and accumbal dopamine release is suppressed in ghrelin knockout mice. Alcohol 2011, 45:341-347.
147. Jerlhag E. Systemic administration of ghrelin induces conditioned place preference and stimulates accumbal dopamine. Addict. Biol. 2008, 13(3-4):358-363.
148. Jiang H., Betancourt L., Smith R.G. Ghrelin amplifies dopamine signaling by cross talk involving formation of growth hormone secretagogue receptor/dopamine receptor subtype 1 heterodimers. Mol. Endocrinol. 2006, 20(8):1772-1785.
149. Johnson S.W., North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 1992, 12:483-488.
150. Kageyama H., Takenoya F., Shiba K., Shoida S. Neuronal circuits involving ghrelin in the hypothalamus-mediated regulation of feeding. Neuropeptides 2010, 44:133-138.
151. Kano M., Ohno-Shosaku T., Hashimotodani Y., Uchigashima M., Watanabe M. Endocannabinoid-mediated control of synaptic transmission. Physiol. Rev. 2009, 89:309-380.
152. Kaufling J., Veinante P., Pawlowski S.A., Freund-Mercier M.J., Barrot M. γ-aminobutyric acid cells with cocaine-induced δFosB in the ventral tegmental area innervate mesolimbic neurons. Biol. Psychiatry 2010, 67:88-92.
153. Kearn C.S., Blake-Palmer K., Daniel E., Mackie K., Glass M. Concurrent stimulation of cannabinoid receptors and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk?. Mol. Pharmacol. 2005, 67:1697-1704.
154. Kern A., Albarran-Zeckler R., Walsh H.E., Smith R.G. Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism. Neuron 2012, 73:317-332.
155. Kim M.S., Lee K.U. Role of hypothalamic 5'-AMP-activated protein kinase in the regulation of food intake and energy homeostasis. J. Mol. Med. 2005, 83:514-520.
156. King S.J., Isaacs A.M., O'Farrell E., Abizaid A. Motivation to obtain preferred foods is enhanced by ghrelin in the ventral tegmental area. Horm. Behav. 2011, 60:572-580.
157. Kirchner H., Gutierrez J.A., Solenberg P.J., Pfluger P.T., Czyzyk T.A., Willency J.A., Schurmann A., Joost H.G., Jandacek R.J., Hale J.E., Heimen M.L., Tschop M.H. GOAT links dietary lipids with the endocrine control of energy balance. Nat. Med. 2009, 15(7):741-745.
158. Kirkham T.C., Rogers E.K. Endocannabinoids in the aetiopathology of obesity- central mechanisms. Drug Discov. Today 2010, 7(3-4):163-168.
159. Kirkham T.C., Williams C.M., Fezza F., Di Marzo V. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting: feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br. J. Pharmacol. 2002, 136:550-557.
160. Kirkham T.C. Cannabinoids and appetite: food craving and food pleasure. Int. Rev. Psychiatry 2009, 21(2):163-171.
161. 2+ signaling via protein kinase A and N-type channel-dependent mechanisms and cross-talk with leptin and orexin. Diabetes 2003, 52:948-956.
162. i via AMPK in hypothalamic arcuate nucleus NPY neurons. Biochem. Biophys. Res. Commun. 2008, 336:388-392.
163. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402:656-660.
164. Kola B., Korbonits M. Shedding light on the intricate puzzle of ghrelin's effects on appetite regulation. J. Endocrinol. 2009, 202:191-198.
165. Kola B., Hubina E., Tucci S.A., Kirkham T.C., Garcia E.A., Mitchell S.E., Williams L.M., Hawley S.A., Hardie D.G., Grossman A.B., Korbonits M. Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP activated protein kinase. J. Biol. Chem. 2005, 280:25196-25201.
166. Kola B., Farkas I., Christ-Crain M., Wittmann G., Lolli F., Amin F., Harvey-White J., Liposits Z., Kunos G., Grossman A.B., Fekete C., Korbonits M. The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system. PLoS One 2008, 3(3):1-8.
167. Kola B., Wittman G., Bodnar I., Amin F., Lim C.T., Olah M., Christ-Crain M., Lolli F., van Thuijl H., Leontiou C.A., Fuzesi T., Dalino P., Isidori A.M., Harvey-White J., Kunos G., Nagy G.M., Grossman A.B., Fekete C., Korbonitis M. The CB-1R receptor mediates the peripheral effects of ghrelin on AMPK activity but not on growth hormone release. J. Fed. Am. Soc. Exp. Biol. 2013, 27(12):5112-5121.
168. Kola B. Role of AMP-activated protein kinase in the control of appetite. J. Neuroendocrinol. 2008, 20:942-951.
169. Kortleven C., Fasano C., Thibault D., Lacaille J.C., Trudeau L.E. The endocannabinoid 2-arachidonoylglycerol inhibits long-term potentiation of glutamatergic synapses onto ventral tegmental area dopamine neurons in mice. Eur. J. Neurosci. 2011, 33:1751-1760.
170. Labouèbe G., Liu S., Dias C., Zou H., Wong J.C.Y., Karunakaran S., Clee S.M., Phillips A.G., Boutrel B., Borgland S.L. Insulin induces long-term depression of ventral tegmental area dopamine neurons via endocannabinoids. Nat. Neurosci. 2013, 16(3):300-310.
171. Lam T.K.T., Schwartz G.J., Rossetti L. Hypothalamic sensing of fatty acids. Nat. Neurosci. 2005, 8(5):579-584.
172. Landgren S., Simms J.A., Thelle D.S., Strandhagen E., Bartlett S.E., Engel J.A., Jerlhag E. The ghrelin signalling system is involved in the consumption of sweets. PLoS One 2011, 6(3):1-9. (e18170).
173. q/11 G proteins. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:19144-19149.
174. Le Merrer J., Becker J.A.J., Befort K., Kieffer B.L. Reward processing by the opioid system in the brain. Physiol. Rev. 2009, 89(4):1379-1412.
175. Lecca S., Melis M., Luchicchi A., Ennas M.G., Castelli M.P., Muntoni A.L., Pistis M. Effects of drugs of abuse on putative rostromedial tegmental neurons: inhibitory afferents to midbrain dopamine cells. Neuropsychopharmacology 2011, 36:589-602.
176. Lecca S., Melis M., Luchicchi A., Muntoni A.L., Pistis M. Inhibitory inputs from rostromedial tegmental neurons regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse. Neuropsychopharmacology 2012, 37:1164-1176.
177. Lee S., Ledri M., Toth B., Marchionni I., Henstridge C.M., Dudok B., Kenesei K., Barna L., Szabo S.I., Renkecz T., Oberoi M., Watanabe M., Limoli C.L., Horvai G., Soltesz I., Katona I. Multiple forms of endocannabinoid and endovanilloid signaling regulate the tonic control of GABA release. J. Neurosci. 2015, 35(27):10039-10057.
178. Lim C.T., Kola B., Korbonits M. AMPK as a mediator of hormonal signalling. J. Mol. Endocrinol. 2010, 44:87-97.
179. Lim C.T., Kola B., Feltrin D., Perez-Tilve D., Tschop M.H., Grossman A.B., Korbonits M. Ghrelin and cannabinoids require the ghrelin receptor to affect cellular energy metabolism. Mol. Cell. Endocrinol. 2013, 365(2):303-308.
180. Liu S., Borgland S.L. Regulation of the mesolimbic dopamine circuit by feeding peptides. Neuroscience 2015, 289:19-42.
181. Lobb C.J., Wilson C.J., Paladini C.A. A dynamic role for GABA receptors on the firing pattern of midbrain dopaminergic neurons. J. Neurophysiol. 2010, 104:403-413.
182. Lopez M., Lage R., Saha A.K., Perez-Tilve D., Vazquez M.J., Varela L., Sangiao-Alvarellos S., Tovar S., Raghay K., Rodriquez-Cuenca S., Deoliveira R.M., Castaneda T., Datta R., Dong J.Z., Culler M., Sleeman M.W., Alvarez C.V., Gallego R., Lelliott C.J., Carling D., Tschop M.H., Dieguez C., Vidal-Puig A. Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab. 2008, 7(5):389-399.
183. Luprica C.R., Riegel A.C. Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction. Neuropharmacology 2005, 48(8):1105-1116.
184. Luprica C.R., Riegel A.C., Hoffman A.F. Marijuana and cannabinoid regulation of brain reward circuits. Br. J. Pharmacol. 2004, 143:227-234.
185. Lutter M., Nestler E.J. Homeostatic and hedonic signals interact in the regulation of food intake. J. Nutr. 2009, 139:629-632.
186. Lutz B., Marsicano G., Maldonado R., Hillard C.J. The endocannabinoid system in guarding against fear: anxiety and stress. Nat. Rev. Neurosci. 2015, 16:705-718.
187. MacDonald A.F., Billington C.J., Levine A.S. Effects of the opioid antagonist naltrexone on feeding induced by DAMGO in the ventral tegmental area and in the nucleus accumbens shell region in the rat. Am. J. Physiol.-Regul. Integr. Comp. Physiol. 2003, 285:R999-R1004.
188. Maccarrone M., Rossi S., Bari M., De Chiara V., Fezza F., Musella A., Gasperi V., Prosperetelli C., Bernardi G., Finazzi-Agro A., Cravatti B.F., Centonze D. Anandamide inhibits metabolism and physiological actions of 2-arachidonylglycerol in the striatum. Nat. Neurosci. 2008, 11(2):152-159.
189. Mackie K., Lai Y., Westenbroek R., Mitchell R. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J. Neurosci. 1995, 15:6552-6561.
190. Mackie K. Distribution of cannabinoid receptors in the central and peripheral nervous system. Handb. Exp. Pharmacol. 2005, 168:299-325.
191. Madsen A.N., Jelsing J., Van de Wall E.H., Vrang N., Larsen P.J., Schwartz G.J. Rimonabant induced anorexia in rodents is not mediated by vagal or sympathetic gut afferents. Neurosci. Lett. 2009, 449:20-23.
192. Mailleux P., Vanderhaeghen J.J. Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 1992, 48:655-668.
193. Malcher-Lopes R., Di S., Marcheselli V.S., Weng F., Stuart C.T., Bazan N.G., Tasker J.G. Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release. J. Neurosci. 2006, 26(24):6643-6650.
194. Malik S., McGlone F., Bedrossian D., Dagher A. Ghrelin modulates brain activity in areas that control appetitive behavior. Cell Metab. 2008, 7:400-409.
195. Maneuf Y.P., Brotchie J.M. Paradoxical action of the cannabinoid WIN 55,212-2 in stimulated and basal cyclic AMP accumulation in rat globus pallidus slices. Br. J. Pharmacol. 1997, 120:1397-1398.
196. Mani B.K., Walker A.K., Lopez Soto E.J., Raingo J., Lee C.E., Perello M., Andrews Z.B., Zigman J.M. Neuroanatomical characterization of a growth horomone secretagogue receptor-green fluorescent protein reporter mouse. J. Comp. Neuro. 2014, 522(16):3644-3666.
197. Margolis E.B., Lock H., Hjelmstad G.O., Fields H.L. The ventral tegmental area revisited: is there an electrophysiological marker for dopaminergic neurons?. J. Physiol. 2006, 577:907-924.
198. Marinelli S., Di Marzo V., Berretta N., Matias I., Maccarrone M., Bernardi G., Mercuri N.B. Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors. J. Neurosci. 2003, 23(8):3136-3144.
199. Marsicano G., Lutz B. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur. J. Neurosci. 1999, 11:4213-4225.
200. Masuda Y., Tanaka T., Inomata N., Ohnuma N., Tanaka S., Itoh Z., Hosoda H., Kojima M., Kangawa K. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem. Biophys. Res. Commun. 2000, 276:905-908.
201. Matias I., Gatta-Cherifi B., Tabarin A., Clarck S., Leste-Lasserre T., Marsicano G., Piazza P.V., Cota D. Endocannabinoids measurement in human saliva as potential biomarker of obesity. PLoS One 2012, 7(7):e42399.
202. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 346:561-564.
203. Matsuda L.A., Bonner T.I., Lolait S.J. Localization of cannabinoid receptor mRNA in rat brain. J. Comp. Neurol. 1993, 327(4):535-550.
204. Matyas F., Urban G.M., Watanabe M., Mackie K., Zimmer A., Freund T.F., Katona I. Identification of the sites of 2-arachidonylglycerol synthesis and action imply retrograde endocannabinoid signalling at both GABAergic and glutamatergic synapses in the ventral tegmental area. Neuropharmacology 2008, 54:95-107.
205. McGarry J.D., Stark M.J., Foster D.W. Hepatic malonyl-CoA levels of fed, fasted and diabetic rats as measured using a simple radioisotopic assay. J. Biol. Chem. 1978, 253(22):8291-8293.
206. McPartland J.M., Guy G.W., Vincenzo D.M. Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system. PLoS One 2014, 9(3):e89566.
207. Mebel D.M., Wong J.C.Y., Dong Y.J., Borgland S.L. Insulin in the ventral tegmental area reduces hedonic feeding and suppresses dopamine concentration via increased reuptake. Eur. J. Neurosci. 2012, 36:2336-2346.
208. Mechoulam R., Parker L.A. The endocannabinoid system and the brain. Ann. Rev. Psychol. 2013, 64:21-47.
209. Melis M., Pistis M. Hub and switches: endocannabinoid signalling in midbrain dopamine neurons. Philos. Trans. R. Soc. B: Biol. Sci. 2012, 367:3276-3285.
210. Melis M., Perra S., Muntoni A.L., Pillolla G., Lutz B., Marsicano G., Di Marzo V., Gessa G.L., Pistis M. Prefrontal cortex stimulation induces 2-Arachidonoyl glycerol-mediated suppression of excitation in dopamine neurons. J. Neurosci. 2004, 24(47):10707-10715.
211. Melis M., Pitis M., Perra S., Muntoni A.L., Pillolla G., Gessa G.L. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J. Neurosci. 2004, 24(1):53-62.
212. Melis T., Succu S., Sanna F., Boi A., Argiolas A., Melis M.R. The cannabinoid antagonist SR 141716A (rimonabant) reduces the increase of extracellular dopamine release in the rat nucleus accumbens induced by a novel high palatable food. Neurosci. Lett. 2007, 419:231-235.
213. Melis M., Muntoni A.L., Pistis M. Endocannabinoids and the processing of value-related signals. Front. Pharmacol. 2012, 3(7):1-7.
214. Melis M., Sagheddu C., De Felice M., Casti A., Madeddu C., Spiga S., Muntoni A.L., Mackie K., Marsicano G., Colombo G., Castelli M.P., Pistis M. Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in Sardinian alcohol-preferring rats. J. Neurosci. 2014, 34(38):112716-112724.
215. Minokoshi Y., Alquier T., Furukawa N., Kim Y.B., Lee A., Xue B., Mu J., Foufelle F., Ferre P., Birnbaum M.J., Stuck B.J., Kahn B.B. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Lett. Nat. 2004, 428:569-574.
216. Mitchell V., Bouret S., Beauvillain J.C., Schilling A., Perret M., Kordon C., Epelbaum J. Comparative distribution of mRNA encoding the growth hormone secretagogue-receptor (GHS-R) in Microcebus murinus (Primate, lemurian) and rat forebrain and pituitary. J. Comp. Neurol. 2001, 429:469-489.
217. Mondal M.S., Date Y., Yamaguchi H., Toshinai K., Tsuruta T., Kangawa K., Nakazato M. Identification of ghrelin and its receptor in neurons of the rat arcuate nucleus. Regul. Pept. 2005, 126:55-59.
218. Moon M., Kim S., Hwang L., Park S. Ghrelin regulates hippocampal neurogenesis in adult mice. Endocr. J. 2009, 56:525-531.
219. Morikawa H., Paladini C.A. Dynamic regulation of midbrain dopamine neuron activity: intrinsic, synaptic and plasticity mechanisms. Neuroscience 2011, 198:95-111.
220. Morton G.J., Blevins J.E., Kim F., Matsen M., Figlewicz D.P. The action of leptin in the ventral tegmental area to decrease food intake is dependent on Jak-2 signaling. Am. J. Physiol.-Endocrinol. Metab. 2009, 297(1):E202-210.
221. Muccioli G., Baragli A., Granata R., Papotti M., Ghigo E. Heterogeneity of ghrelin/growth hormone secretagogue receptors: toward the understanding of the molecular identity of novel ghrelin/GHS receptors. Neuroendocrinology 2007, 86:147-164.
222. Mucha R.F., Iversen S.D. Increased food intake after opioid microinjections into nucleus accumbens and ventral tegmental area of rat. Brain Res. 1986, 397:214-224.
223. Mudge A., Leeman S., Fischbach G.D. Enkephalin inhibits release of substance P from sensory neurons in culture and decreases action potential duration. Proc. Natl. Acad. Sci. U.S.A. 1979, 76:526-530.
224. Muller T.D., Nogueiras R., Andermann M.N., Andrews Z.B., Anker S.D., Argente J., Batterham R.I., Benoit S.C., Bowers C.J., Broglio F., Casanueva F.F., D'Alessio D., Depoortere I., Geliebter A., Ghigo E., Cole P.A., Cowley M., Cummings D.E., Dagher A., Diano S., Dickson S.I., Dieguez C., Granata R., Grill H.J., Grove K., Habegger K.M., Heppner K., Heiman M.L., Holsen L., Holst B., Inui A., Jansson J.O., Kirchner H., Korbonits M., Laferrerem B., LeRoux C.W., Lopez M., Morin S., Nakazato M., Nass R., Perez-Tilve D., Pfluger P.T., Schwartz T.W., Seeley R.J., Sleeman M., Sun Y., Sussel L., Tong J., Thorner M.O., Van Der Lely A.J., Van Der Ploeg L.H.T., Zigman J.M., Kojima M., Kangawa K., Smith R.G., Horvath T., Tschop M.H. Ghrelin. Mol. Metab. 2015, 1-24.
225. Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993, 365:61-65.
226. Musella A., De Chiara V., Rossi S., Prosperetti C., Bernardi G., Maccarrone M., Centonze D. TRPV1 channels facilitate glutamate transmission in the striatum. Mol. Cell. Neurosci. 2009, 40:89-97.
227. Nair-Roberts R.G., Chatelain-Bradie S.D., Benson E., White-Cooper H., Bolam J.P., Ungless M.A. Stereological estimates of dopaminergic, GABAergic and glutamatergic neurons in the ventral tegmental area, substantia nigra and retrorubral field in the rat. Neuroscience 2008, 154(4-2):1024-1031.
228. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., Matsukura S. A role for ghrelin in the central regulation of feeding. Nature 2001, 409:194-198.
229. Naleid A.M., Grace M.K., Cummings D.E., Levine A.S. Ghrelin induces feeding in the mesolimbic reward pathway between the ventral tegmental area and the nucleus accumbens. Peptides 2005, 26:2274-2279.
230. Navarro M., Carrera M., Fratta W., Valverde O., Cossu G., Fattore L., Chowen J.A., Gomez R., del Arco I., Villanua M.A., Maldonado R., Koob G.F., Rodriguez de Fonseca F. Functional interaction between opioid and cannabinoid receptors in drug self-administration. J. Neurosci. 2001, 21:5344-5350.
231. Neary N.M., Druce M.R., Small C.J., Bloom S.R. Acylated ghrelin stimulates food intake in the fed and fasted states but desacylated ghrelin has no effect. Gut 2006, 55:135.
232. 2+ signals in cerebellar granule neurons in culture. J. Neurosci. 1999, 19:8765-8777.
233. Noel M.B., Gratton A. Electrochemical evidence of increased dopamine transmission in prefrontal cortex and nucleus accumbens elicited by ventral tegmental mu receptor activation in freely behaving rats. Synapse 1995, 21:110-122.
234. Nogueiras R., Romero-Pico A., Vazquez M.J., Novelle M.G., Lopez M., Diequez C. The opioid system and food intake: homeostatic and hedonic mechanisms. Obes. Facts 2012, 5:196-207.
235. Obici S., Feng Z., Morgan K., Stein D., Karkanias G., Rossetti L. Central administration of oleic acid inhibits glucose production and food intake. Diabetes 2002, 51(2):271-275.
236. Obici S., Feng Z., Arduini A., Conti R., Rossetti L. Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nat. Med. 2003, 9(6):756-761.
237. Oddi S., Fezza F., Pasquariello N., De Simone C., Rapino C., Dainese E., Finazzi-Agro A., Maccarrone M. Evidence for the intracellular accumulation of anadamide in adiposomes. Cell. Mol. Life Sci. 2008, 65:840-850.
238. Ohno-Shosaku T., Maejima T., Kano M. Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 2001, 29:729-738.
239. Oleson E.B., Cheer J.F. A brain on cannabinoids: the role of dopamine release in reward seeking. Cold Spring Harbor Perspect. Med. 2012, 2(8):1-14.
240. Oleson E.B., Beckert M.V., Morra J.T., Lansink C.S., Cachope R., Abdullah R.A., Loriaux A.L., Schetters D., Pattij T., Roitman M.F., Lichtman A.H., Cheer J.F. Endocannabinoids shape accumbal encoding of cue-motivated behaviour via CB-1 receptor activation in the ventral tegmentum. Neuron 2012, 73(2):360-373.
241. Olszewski P.K., Alsio J., Schioth H.B., Levine A.S. Opioids as facilitators of feeding: can any food be rewarding?. Physiol. Behav. 2011, 104:105-110.
242. Omar B., Zmuda-Trzebiatowska E., Manganiello V., Goransson O., Degerman E. Regulation of AMP-activated protein kinase by cAMP in adipocytes: roles for phosphodiesterases, protein kinase B, protein kinase A, epac and lipolysis. Cell. Signal. 2009, 21(5):760-766.
243. Omelchenko N., Sesack S.R. Glutamate synaptic inputs to ventral tegmental area neurons in the rat derive primarily from subcortical sources. Neuroscience 2007, 146(3):1259-1274.
244. Omelchenko N., Sesack S.R. Ultrastructural analysis of local collaterals of rat central tegmental area neurons: GABA phenotype and synapses onto dopamine and GABA cells. Synapse 2009, 63:895-906.
245. Osei-Hyiaman D., DePetrillo M., Pacher P., Liu J., Radaeva S., Batkai S., Harvey-White J., Mackie K., Offertaler L., Wang L., Kunos G. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J. Clin. Invest. 2005, 115(5):1298-1305.
246. Pagotto U., Cervino C., Vincennati V., Marsicano G., Lutz B., Pasquali R. How many sites of action for endocannabinoids to control energy metabolism?. Int. J. Obes. 2006, 30:539-543.
247. Papotti M., Ghe C., Cassoni P., Catapano F., Deghenghi R., Ghigo E., Muccioli G. Growth hormone secretagogue binding sites in peripheral human tissues. J. Clin. Endocrinol. Metab. 2000, 85:3803-3807.
248. Parolaro D., Rubino T., Vigano D., Massi P., Guidali C., Realini N. Cellular mechanisms underlying the interaction between cannabinoid and opioid system. Curr. Drug Targets 2010, 11(4):393-405.
249. Patterson M., Murphy K.G., Le Roux C.W., Ghatei M.A., Bloom S.R. Characterization of ghrelin-like immunoreactivity in human plasma. J. Clin. Endocrinol. Metab. 2005, 90(4):2205-2211.
250. Perello M., Sakata I., Birnbaum S., Chuang J.C., Osborne-Lawrence S., Rovinsky S.A., Woloszyn J., Yanagisawa M., Lutter M., Zigman J.M. Ghrelin increases the rewarding value of high-fat diet in an orexin-dependent manner. Biol. Psychiatry 2010, 67:880-886.
251. Perio A., Barnouin M.C., Poncelet M., Soubrie P. Activity of SR.;1; 141716 on post reinforcement pauses in operant responding for sucrose reward in rats. Behav. Pharmacol. 2001, 12:641-645.
252. Perrotti L., Bolanos C.A., Choi K.H., Russo S.J., Edwards S., Ulery P.G., Wallace D.L., Self D.W., Nestler E.J., Barrot M. DeltaFosB accumulates in a GABAergic cell population in the posterior tail of the ventral tegmental area after psychostimulant treatment. Eur. J. Neurosci. 2005, 21(10):2817-2824.
253. 2 receptors. Pharmacol. Ther. 1997, 74(2):129-180.
254. Pertwee R.G. Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities. Philos. Trans. R. Soc. B 2012, 367:3353-3363.
255. Pfluger P.T., Kirchner H., Gunnel S., Schrott B., Perez-Tilve D., Fu S., Benoit S.C., Horvath T., Joost H.G., Wortley K.E., Sleeman M.W., Tschop M.H. Simultaneous deletion of ghrelin and its receptor increases motor activity and energy expenditure. Am. J. Physiol. Gasterointest. Liver Physiol. 2008, 294:G610-G618.
256. Pinto S., Roseberry A.G., Liu H., Diano S., Shanabrough M., Cai X., Friedman J.M., Horvath T.L. Rapid rewiring of arcuate nucleus feeding circuit by leptin. Science 2004, 304(5667):110-115.
257. Poncelet M., Maruani J., Calassi R., Soubrie P. Overeating: alcohol and sucrose consumption decrease in CB1 receptor deleted mice. Neurosci. Lett. 2003, 343:216-218.
258. Ragnauth A., Ruegg H., Bodnar R.J. Evaluation of opioid receptor subtype antagonist effects in the ventral tegmental area upon food intake under deprivation, glucoprivic and palatable conditions. Brain Rev. 1997, 767:8-16.
259. Rashidy-Pour A., Pahlevani P., Vaziri A., Shaigani P., Zarepour L., Vafaei A.A., Haghparast A. Involvement of CB1 receptors in the ventral tegmental area in the potentiation of morphine rewarding properties in acquisition but not expression in the conditioned place preference model. Behav. Brain Res. 2013, 15(247):259-267.
260. Ravinet Trillou C., Delgorge C., Menet C., Arnone M., Soubrie P. CB1 cannabinoid-receptor knockout in mice leads to leanness: resistance to diet-induced obesity and enhanced leptin sensitivity. Int. J. Obes. Relat. Metab. Disord. 2004, 28:640-648.
261. Rediger A., Tarnow P., Bickenbach A., Schaefer M., Krude H., Grüters A., Biebermann H. Heterodimerization of hypothalamic G-protein-coupled receptors involved in weight regulation. Obes. Facts 2009, 2:80-86.
262. Richardson N.R., Gratton A. Behavior-relevant changes in nucleus accumbens dopamine transmission elicited by food reinforcement: an electrochemical study in rat. J. Neurosci. 1996, 16:8160-8169.
263. Riegel A.C., Luprica C.R. Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area. J. Neurosci. 2004, 24(49):11070-11078.
264. Rinaldi-Carmona M., Barth F., Heaulme M., Shire D., Calandra B., Congy C., Martinez S., Maruani J., Neliat G., Caput D., Ferrara P., Soubrie P., Breliere J.C., Le Fur G. SR 141716A: a potent and selective antagonist of the brain cannabinoid receptor. Fed. Eur. Biochem. Soc. Lett. 1994, 350:240-244.
265. Rios C., Gomes I., Devi L.A. μ opioid and CB1 cannabinoid receptor interactions reciprocal inhibition of receptor signalling and neuritogensis. Br. J. Pharmacol. 2006, 148:387-395.
266. Rubovitch V., Gafni M., Sarne Y. The cannabinoid agonist DALN positively modulates L-type voltage dependent calcium-channels in N18TG2 neuroblastoma cells. Mol. Brain. Res. 2002, 101:93-102.
267. Salamone J.D., Zigmound M.J., Stricker E.M. Characterization of the impaired feeding behavior in rats given haloperidol or dopamine-depleting brain lesions. Neuroscience 1990, 39:17-24.
268. Salamone J.D., Mahan M.J., Rogers S. Ventrolateral striatal dopamine depletions impair feeding and food handling in rats Pharmacology. Biochem. Behav. 1993, 44(3):605-610.
269. Sanchez C., Galve-Roperh I., Rueda D., Guzman M. Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the δ9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes. Mol. Pharmacol. 1998, 54:834-843.
270. Sanchis-Segura C., Cline B., Marsicano G., Lutz B., Spanagel R. Reduced sensitivity to reward in CB1 knockout mice. Psychopharmacology (Berl.) 2004, 176:223-232.
271. Schellekens H., Dinan T.G., Cryan J.F. Lean mean fat reducing ghrelin machine: hypothalamic ghrelin and ghrelin receptors as therapeutic targets in obesity. Neuropharmacology 2010, 58:2-16.
272. Schellekens H., Finger B.C., Dinan T.G., Cryan J.F. Ghrelin signalling and obesity: at the interface of stress: mood and food reward. Pharmacol. Ther. 2012, 135:316-326.
273. Schellekens H., Van Oeffelen W.E., Dinan T.G., Cryan J.F. Promiscuous dimerization of the growth hormone secretagogue receptor (GHS-R1a) attenuates ghrelin-mediated signaling. J. Biol. Chem. 2013, 288:181-191.
274. Schlicker E., Kathmann M. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol. Sci. 2001, 22(11):565-572.
275. Schuette L.M., Gray C.C., Currie P.J. Microinjection of ghrelin into the ventral tegmental area potentiates cocaine-induced conditioned place preference. J. Behav. Brain Sci. 2013, 3:576-580.
276. Shimbara T., Mondal M.S., Kawagoe T., Toshinai K., Koda S., Yamaguchi H., Date Y., Nakazato M. Central administration of ghrelin preferentially enhances fat ingestion. Neurosci. Lett. 2004, 369:75-79.
277. Shrestha Y.B., Wickwire K., Giraudo S. Effect of reducing hypothalamic ghrelin receptor gene expression on energy balance. Peptides 2009, 30:1336-1341.
278. Shuto Y., Shibasaki T., Wada K., Parhar I., Kamegai J., Sugihara H., Oikawa S., Wakabayashi I. Generation of polyclonal antiserum against the growth hormone secretagogue receptor (GHS-R): evidence that the GHS-R exists in the hypothalamus, pituitary and stomach of rats. Life Sci. 2001, 68(9):991-996.
279. Simiand J., Keane M., Keane P.E., Soubrié P. SR.;1; 141716, a CB1 cannabinoid receptor antagonist: selectively reduces sweet food intake in marmoset. Behav. Pharmacol. 1998, 9:179-181.
280. Sinnayah P., Jobst E.E., Rathner J.A., Caldera-Siu A.D., Tonelli-Lemos L., Eusterbrock A.J., Enriori P.J., Pothos E.N., Grove K.L., Cowley M.A. Feeding induced by cannabinoids is mediated independently of the melanocortin system. PLoS One 2008, 3(5):e2202.
281. Skibicka K.P., Hansson C., Alvarez-crespo M., Friberg P.A., Dickson S.L. Ghrelin directly targets the ventral tegmental area to increase food motivation. Neuroscience 2011, 180:129-137.
282. Skibicka K.P., Hansson C., Egecioglu E., Dickson S.L. Role of ghrelin in food reward: impact of ghrelin on sucrose self-administration and mesolimbic dopamine and acetylcholine receptor gene expression. Addict. Biol. 2012, 17(1):95-107.
283. Solinas M., Goldberg S.R. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems. Neuropsychopharmacology 2005, 30:2035-2045.
284. Solinas M., Justinova Z., Goldberg S.R., Tanda G. Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nuclear accumbens shell in rats. J. Neurochem. 2006, 98:408-419.
285. Spanagel R., Herz A., Shippenberg T.S. Opposing tonically active endogenous opioid system mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:2046-2050.
286. Starowicz K., Nigam S., Di Marzo V. Biochemistry and pharmacology of endovanilloids. Pharmacol. Ther. 2007, 114:13-33.
287. Stoyanova I.I. Ghrelin: a link between ageing, metabolism: and neurodegenerative disorders. Neurobiol. Dis. 2014, 72:72-83.
288. Sugiura T., Kondo S., Sukagawa A., Nakane S., Shinoda A., Itoh K., Yamashita A., Waku K. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 1995, 215:89-97.
289. 2+ in neuroblastoma x glioma hybrid NG108-15 cells. Biochem. Biophys. Res. Commun. 1996, 229:58-64.
290. Sugiura T., Kodaka T., Kondo S., Tonegawa T., Nakane S., Kishimoto S., Yamashita A., Waku K. Inhibition by 2-arachidonylglycerol, a novel type of possible neuromodulator: of the depolarisation-induced increase in intracellular free calcium in neuroblastoma x glioma hybrid NG108-15 cells. Biochem. Biophys. Res. Commun. 1997, 233:207-210.
291. Sun Y., Wang P., Zheng H., Smith R.G. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:4679-4684.
292. Suzuki K., Simpson K.A., Minnion J.S., Shillito J.C., Bloom S.R. The role of gut hormones and the hypothalamus in appetite regulation. Endocr. J. 2010, 57(5):359-372.
293. Svizenska I., Duboyy P., Sulcova A. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands, and functional involvement in nervous system structures-a short review Pharmacology. Biochem. Behav. 2008, 90(4):501-511.
294. Szabo B., Siemes S., Wallmichrath I. Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids. Eur. J. Neurosci. 2002, 15:2057-2061.
295. Tanda G., Pontieri F., Di Chiara G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common μ1 opioid receptor mechanism. Science 1997, 270:2048-2050.
296. Tannenbaum G.S., Lapointe M., Beaudet A., Howard A.D. Expression of growth hormone secretagogue-receptors by growth hormone-releasing hormones in the mediobasal hypothalamus. Endocrinology 1998, 139(10):4420-4423.
297. Tena-Sempere M. Ghrelin and reproduction: ghrelin as novel regulator of the gonadotropic axis. Vitam. Horm. 2008, 77:285-300.
298. Thompson J.L., Borgland S.L. Presynaptic leptin action suppresses excitatory synaptic transmission onto ventral tegmental area dopamine neurons. Biol. Psychiatry 2013, 73:860-868.
299. Tolle V., Bassant M.H., Zizzari P., Poindessous-Jazat F., Tomasetto C., Epelbaum J., Bluet-Pajot M.T. Ultradian rhythmicity of ghrelin secretion in relation with GH, feeding behaviour: and sleep-wake patterns in rats. Endocrinology 2002, 143:1353-1361.
300. Tong J., Dave N., Mugundu G.M., Davis H.W., Gaylinn B.D., Thorner M.O., Tschop M.H., D'Alessio D., Desai P.B. The pharamacokinetics of acyl, des-acyl: and total ghrelin in healthy human subjects. Eur. J. Endocrinol. 2013, 168:821-828.
301. Toshinai K., Yamaguchi H., Sun Y., Smith R.G., Yamanaka A., Sakurai T., Date Y., Mondal M.S., Shimbara T., Kawagoe T., Murakami N., Miyazato M., Kangawa K., Nakazato M. Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor. Endocrinology 2006, 147(5):2306-2314.
302. Tschop M., Smiley D.L., Heiman M.L. Ghrelin induces adiposity in rodents. Nature 2000, 407(6806):908-913.
303. Tsou K., Brown S., Sanudo-Pena M.C., Mackie K., Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 1998, 83:393-411.
304. Tucci S.A., Rogers E.K., Korbonits M., Kirkham T.C. The cannabinoid CB1 receptor antagonist SR 141716 blocks the orexigenic effects of intrahypothalamic ghrelin. Pharmacology 2004, 143:520-523.
305. 1 cannabinoid receptor. J. Mol. Endocrinol. 2010, 44:75-85.
306. Twitchell W., Brown S., Mackie K. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J. Neurophysiol. 1997, 78:43-50.
307. Uchigashima M., Narushima M., Fukaya M., Katona I., Kano M., Watanabe M. Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. J. Neurosci. 2007, 27(14):3663-3676.
308. Van Der Lely A.J., Tschop M., Heiman M., Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr. Rev. 2004, 25(3):426-457.
309. Van Der Plasse G., Van Zessen R., Luijendijk M.C., Erkan H., Stuber G.D., Ramakers G.M., Adan R.A. Modulation of cue-induced firing of ventral tegmental area dopamine neurons by leptin and ghrelin. Int. J. Obes. 2015, 39(12):1742-1749.
310. Verhulst P.J., Janssen S., Tack J., Depoortere I. Role of the AMP-activated protein kinase (AMPK) signaling pathway in the orexigenic effects of endogenous ghrelin. Regul. Pept. 2012, 173(1-3):27-35.
311. Verty A.N., McGregor I.S., Mallet P.E. Paraventricular hypothalamic CB(1) cannabinoid receptors are involved in the feeding stimulatory effects of delta(9)-tetrahydrocannabinol. Neuropharmacology 2005, 49:1101-1109.
312. Viveros M.P., Rodriguez de Fonseca F., Bermudez-Silva F.J., McPartland J.M. Critical role of the endocannabinoid system in the regulation of food intake and energy metabolism, with phylogenetic, developmental, and pathophysiological implications. Endocr. Metab. Immune Disord. Drug Targets 2008, 8(3):220-230.
313. Viveros M.P., Llorente R., Suarez J., Llorente-Berzal A., Lopez-Gallardo M., de Fonseca F.R. The endocannabinoid system in critical neurodevelopmental periods: sex differences and neuropsychiatric implications. J. Psychopharmacol. (Oxf.) 2011, 26(1):164-176.
314. Volante M., Allia E., Gugliotta P., Funaro A., Broglio F., Deghenghi R., Muccioli G., Ghigo E., Papotti M. Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors. J. Clin. Endocrinol. Metab. 2002, 87:1300-1308.
315. Wamsteeker Cusulin J.I., Fuzesi T., Inoue W., Bains J.S. Glucocorticoid feedback uncovers retrograde opioid signaling at hypothalamic synapses. Nat. Neurosci. 2013, 16:596-604.
316. Wang H., Luprica C.R. Release of endogenous cannabinoids from ventral tegmental area dopamine neurons and the modulation of synaptic processes. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2014, 52:24-27.
317. Wang H., Treadway T., Covey D.P., Cheer J.F., Luprica C.R. Cocaine-induced endocannabinoid mobilization in the ventral tegmental area. Cell Rep. 2015, 2(12):1997-2008.
318. Weinburg Z.Y., Nicholson M.L., Currie P.J. 6-Hydroxydopamine lesions of the ventral tegmental area suppress ghrelin's ability to elicit food-reinforced behavior. Neurosci. Lett. 2011, 499(2):70-73.
319. Wellman M., Abizaid A. Growth hormone secretagogue receptor dimers: a new pharmacological target. eNeuro 2015, 2(2):e0053-14.
320. Wellman P.J., Clifford P.S., Rodriguez J.A., Hughes S., Di Francesco C., Melotto S., Tessari M., Corsi M., Bifone A., Gozzi A. Brain reinforcement system function is ghrelin dependent: studies in the rat using pharmacological fMRI and intracranial self-stimulation. Addict. Biol. 2012, 17(5):908-919.
321. Wellman P.J., Clifford P.S., Rodriguez J.A. Ghrelin and ghrelin receptor modulation of psychostimulant action. Front. Neurosci. 2013, 7(171):1-12.
322. Wenger T., Moldrich G., Furst S. Neuromorphological background of cannabis addiction. Brain Res. Bull. 2003, 61:125-128.
323. Werner N., Koch J. Effects of the cannabinoid antagonists AM281 and AM630 on deprivation-induced intake in Lewis rats. Brain Res. 2003, 967:290-292.
324. Willesen M.G., Kristensen P., Romer J. Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat. Neuroendocrinology 1999, 70(5):306-316.
325. Williams C.M., Kirkham T.C. Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. Psychopharmacology (Berl.) 1999, 14:315-317.
326. Williams C.M., Kirkham T.C. Observational analysis of feeding induced by δ9-THC and anandamide. Physiol. Behav. 2002, 76:241-250.
327. Williams C.M., Kirkham T.C. Reversal of delta 9-THC hyperphagia by SR. 141716 and naloxone but not dexfenfluramine. Pharmacol. Biochem. Behav. 2002, 71:333-340.
328. Wilson R.I., Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 2001, 410:588-592.
329. Wittmann G., Deli L., Kallo I., Hrabovszky E., Watanabe M., Liposits Z., Fekete C. Distribution of type 1 cannabinoid receptor (CB1)-immunoreactive axons in the mouse hypothalamus. J. Comp. Neurol. 2007, 503:270-279.
330. 2+/ calmodulin-dependent protein kinase kinasebeta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2005, 2:21-33.
331. Wren A.M., Seal L.J., Cohen M.A., Brynes A.E., Frost G.S., Murphy K.G., Dhillo W.S., Ghatei M.A., Bloom S.R. Ghrelin enhances appetite and increases food intake in humans. J. Clin. Endocrinol. Metab. 2001, 86(12):5992-5995.
332. Wren A.M., Small C.J., Abbott C.R., Dhillo W.S., Seal L.J., Cohen M.A., Batterham R.L., Taheri S., Stanley S.A., Ghatei M.A., Bloom S.R. Ghrelin causes hyperphagia and obesity in rats. Diabetes 2001, 50(11):2540-2547.
333. Xue B., Kahn B.B. AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues. J. Physiol. 2006, 574:73-83.
334. Yamaguchi T., Sheen W., Morales M. Glutamatergic neurons are present in the rat ventral tegmental area. Eur. J. Neurosci. 2007, 25:106-118.
335. Yang J., Brown M.S., Liang G., Grishin N.V., Goldstein J.L. Identification of the acyltransferase that octanoylates ghrelin: an appetite stimulating peptide hormone. Cell 2008, 132:387-396.
336. Yang Y., Atasoy D., Su H.H., Sternson S.M. Hunger states switch a flip-flop memory circuit via a synaptic AMPK-dependent positive feedback loop. Cell 2011, 146:992-1003.
337. Yin Y., Li Y., Zhang W. The growth hormone secretagogue receptor: its intracellular signaling and regulation. Int. J. Mol. Sci. 2014, 15:4837-4855.
338. Yoshida T., Uchigashima M., Yamasaki M., Katona I., Yamazaki M., Sakimura K., Kano M., Yoshioka M., Watanabe M. Unique inhibitory synapse with particularly rich endocannabinoid signaling machinery on pyramidal neurons in basal amygdaloid nucleus. Proc. Natl. Acad. Sci. U.S.A. 2011, 108(7):3059-3064.
339. Zbucki R.L., Sawicki B., Hryniewicz A., Winnicka M.M. Cannabinoids enhance gastric X/A- like cells activity. Folia Histochem. Cytobiol. 2008, 46(2):219-224.
340. Zeltser L.M., Seeley R.J., Tschop M.H. Synaptic plasticity in neuronal circuits regulating energy balance. Nat. Neurosci. 2012, 15(10):1336-1342.
341. Zigman J.M., Nakano Y., Coppari R., Balthasar N., Marcus J.N., Lee C.E., Jones J.E., Deysher A.E., Waxman A.R., White R.D., Williams T.D., Lachey J.L., Seeley R.J., Lowell B.B., Elmquist J.K. Mice lacking ghrelin receptors resist development of diet induced obesity. J. Clin. Invest. 2005, 115:3564-3572.
342. Zigman J.M., Jones J.E., Lee C.E., Saper C.B., Elmquist J.K. Expression of ghrelin receptor mRNA in the rat and the mouse brain. J. Comp. Neurol. 2006, 494:528-548.
343. Zygmunt P.M., Petersson J., Andersson D.A., Chuang H., Sorgard M., Di Marzo V., Julius D., Hogestatt E.D. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 1999, 400:452-457.
344. Zygmunt P.M., Ermund A., Movahed P., Andersson D.A., Simonsen C., Jonsson B.A., Blomgren A., Birnir B., Bevan S., Eschalier A., Mallet C., Gomis A., Hogestatt E.D. Monoacylglycerols activate TRPV1-a link between phospholipase C and TRPV1. PLoS One 2013, 8:e81618.